RxDoctor Payments Data
★ My doctorsLook up a doctor →

Steven Wodzinski

Greensburg, PANPI 1730185943

Payments from drug & device makers

$2,862in general payments, 2019–2025

Across 158 payments — averaging $18.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$781
  • AstraZeneca$582
  • Boehringer Ingelheim$248
  • Novartis$234
  • Mylan Specialty L.p.$171
  • Regeneron Healthcare Solutions, Inc.$153
  • plus $693 from 14 others

What the payments were for

  • Food & beverage$2,79598%
  • Education$682%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK46$781
AstraZeneca27$582
Boehringer Ingelheim15$248
Novartis8$234
Mylan Specialty L.p.10$171
Regeneron Healthcare Solutions, Inc.5$153
Actelion Pharmaceuticals US, Inc.5$150
Genentech USA, Inc.12$139
Electromed, Inc.9$86
Jazz Pharmaceuticals Inc.4$64
Paratek Pharmaceuticals, Inc.4$55
Sanofi3$49
Philips North America LLC2$32
Circassia Inc.2$26
Advanced Respiratory, Inc1$17
AbbVie1$17
Cumberland Pharmaceuticals, Inc.1$16
Grifols USA, LLC1$15
Merck1$13
Insmed, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →